vs

Side-by-side financial comparison of Bowman Consulting Group Ltd. (BWMN) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $129.0M, roughly 1.5× Bowman Consulting Group Ltd.). REPLIGEN CORP runs the higher net margin — 6.7% vs 1.5%, a 5.2% gap on every dollar of revenue. On growth, Bowman Consulting Group Ltd. posted the faster year-over-year revenue change (13.9% vs 13.6%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $8.1M). Over the past eight quarters, Bowman Consulting Group Ltd.'s revenue compounded faster (16.6% CAGR vs 14.4%).

SLR Consulting is a privately owned international sustainability consultancy with offices in Europe, North America, South America, Australasia, and Africa. In 2019, it reported revenues of £150.8 million. Its purpose is ‘Making Sustainability Happen’, which it achieves through its global team of expert advisors and technicians, who partner with clients to tackle some of the world’s most complex sustainability challenges. Its ultimate owner is Solar Holdings Topco Limited.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

BWMN vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.5× larger
RGEN
$197.9M
$129.0M
BWMN
Growing faster (revenue YoY)
BWMN
BWMN
+0.3% gap
BWMN
13.9%
13.6%
RGEN
Higher net margin
RGEN
RGEN
5.2% more per $
RGEN
6.7%
1.5%
BWMN
More free cash flow
RGEN
RGEN
$9.4M more FCF
RGEN
$17.6M
$8.1M
BWMN
Faster 2-yr revenue CAGR
BWMN
BWMN
Annualised
BWMN
16.6%
14.4%
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BWMN
BWMN
RGEN
RGEN
Revenue
$129.0M
$197.9M
Net Profit
$2.0M
$13.3M
Gross Margin
55.0%
52.5%
Operating Margin
3.2%
9.0%
Net Margin
1.5%
6.7%
Revenue YoY
13.9%
13.6%
Net Profit YoY
-66.7%
143.9%
EPS (diluted)
$0.13
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BWMN
BWMN
RGEN
RGEN
Q4 25
$129.0M
$197.9M
Q3 25
$126.0M
$188.8M
Q2 25
$122.1M
$182.4M
Q1 25
$112.9M
$169.2M
Q4 24
$113.2M
$174.1M
Q3 24
$113.9M
$154.9M
Q2 24
$104.5M
$154.1M
Q1 24
$94.9M
$151.3M
Net Profit
BWMN
BWMN
RGEN
RGEN
Q4 25
$2.0M
$13.3M
Q3 25
$6.6M
$14.9M
Q2 25
$6.0M
$14.9M
Q1 25
$-1.7M
$5.8M
Q4 24
$5.9M
$-30.3M
Q3 24
$771.0K
$-654.0K
Q2 24
$-2.1M
$3.3M
Q1 24
$-1.6M
$2.1M
Gross Margin
BWMN
BWMN
RGEN
RGEN
Q4 25
55.0%
52.5%
Q3 25
53.1%
53.2%
Q2 25
53.7%
50.0%
Q1 25
51.4%
53.6%
Q4 24
53.2%
26.1%
Q3 24
52.4%
50.0%
Q2 24
52.5%
49.8%
Q1 24
50.6%
49.5%
Operating Margin
BWMN
BWMN
RGEN
RGEN
Q4 25
3.2%
9.0%
Q3 25
4.2%
8.9%
Q2 25
7.4%
7.6%
Q1 25
1.0%
3.9%
Q4 24
1.2%
-17.7%
Q3 24
0.4%
-5.1%
Q2 24
-1.2%
1.0%
Q1 24
-2.8%
1.3%
Net Margin
BWMN
BWMN
RGEN
RGEN
Q4 25
1.5%
6.7%
Q3 25
5.3%
7.9%
Q2 25
4.9%
8.2%
Q1 25
-1.5%
3.4%
Q4 24
5.2%
-17.4%
Q3 24
0.7%
-0.4%
Q2 24
-2.0%
2.2%
Q1 24
-1.6%
1.4%
EPS (diluted)
BWMN
BWMN
RGEN
RGEN
Q4 25
$0.13
$0.24
Q3 25
$0.37
$0.26
Q2 25
$0.34
$0.26
Q1 25
$-0.11
$0.10
Q4 24
$0.37
$-0.55
Q3 24
$0.04
$-0.01
Q2 24
$-0.13
$0.06
Q1 24
$-0.11
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BWMN
BWMN
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$11.1M
$767.6M
Total DebtLower is stronger
$57.6M
$542.2M
Stockholders' EquityBook value
$261.1M
$2.1B
Total Assets
$579.7M
$2.9B
Debt / EquityLower = less leverage
0.22×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BWMN
BWMN
RGEN
RGEN
Q4 25
$11.1M
$767.6M
Q3 25
$16.2M
$748.7M
Q2 25
$15.5M
$708.9M
Q1 25
$10.7M
$697.2M
Q4 24
$6.7M
$757.4M
Q3 24
$11.7M
$784.0M
Q2 24
$23.1M
$809.1M
Q1 24
$11.7M
$780.6M
Total Debt
BWMN
BWMN
RGEN
RGEN
Q4 25
$57.6M
$542.2M
Q3 25
$29.8M
$537.9M
Q2 25
$32.0M
Q1 25
$36.4M
Q4 24
$38.1M
$525.6M
Q3 24
$36.4M
Q2 24
$38.8M
Q1 24
$26.8M
Stockholders' Equity
BWMN
BWMN
RGEN
RGEN
Q4 25
$261.1M
$2.1B
Q3 25
$261.8M
$2.1B
Q2 25
$249.6M
$2.1B
Q1 25
$244.1M
$2.0B
Q4 24
$246.1M
$2.0B
Q3 24
$243.2M
$2.0B
Q2 24
$235.6M
$2.0B
Q1 24
$167.3M
$2.0B
Total Assets
BWMN
BWMN
RGEN
RGEN
Q4 25
$579.7M
$2.9B
Q3 25
$510.2M
$2.9B
Q2 25
$538.2M
$2.9B
Q1 25
$528.7M
$2.9B
Q4 24
$505.9M
$2.8B
Q3 24
$497.0M
$2.8B
Q2 24
$463.4M
$2.9B
Q1 24
$420.5M
$2.8B
Debt / Equity
BWMN
BWMN
RGEN
RGEN
Q4 25
0.22×
0.26×
Q3 25
0.11×
0.26×
Q2 25
0.13×
Q1 25
0.15×
Q4 24
0.15×
0.27×
Q3 24
0.15×
Q2 24
0.16×
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BWMN
BWMN
RGEN
RGEN
Operating Cash FlowLast quarter
$9.4M
$25.7M
Free Cash FlowOCF − Capex
$8.1M
$17.6M
FCF MarginFCF / Revenue
6.3%
8.9%
Capex IntensityCapex / Revenue
0.9%
4.1%
Cash ConversionOCF / Net Profit
4.76×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$33.4M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BWMN
BWMN
RGEN
RGEN
Q4 25
$9.4M
$25.7M
Q3 25
$10.2M
$48.1M
Q2 25
$4.3M
$28.6M
Q1 25
$12.0M
$15.0M
Q4 24
$11.9M
$39.2M
Q3 24
$6.8M
$49.3M
Q2 24
$3.1M
$42.2M
Q1 24
$2.5M
$44.7M
Free Cash Flow
BWMN
BWMN
RGEN
RGEN
Q4 25
$8.1M
$17.6M
Q3 25
$10.1M
$43.4M
Q2 25
$4.2M
$21.5M
Q1 25
$11.0M
$11.4M
Q4 24
$11.7M
$33.6M
Q3 24
$6.6M
$42.3M
Q2 24
$2.7M
$37.4M
Q1 24
$2.3M
$36.4M
FCF Margin
BWMN
BWMN
RGEN
RGEN
Q4 25
6.3%
8.9%
Q3 25
8.0%
23.0%
Q2 25
3.4%
11.8%
Q1 25
9.7%
6.8%
Q4 24
10.4%
19.3%
Q3 24
5.8%
27.3%
Q2 24
2.6%
24.3%
Q1 24
2.4%
24.0%
Capex Intensity
BWMN
BWMN
RGEN
RGEN
Q4 25
0.9%
4.1%
Q3 25
0.0%
2.5%
Q2 25
0.1%
3.9%
Q1 25
0.9%
2.1%
Q4 24
0.2%
3.2%
Q3 24
0.2%
4.5%
Q2 24
0.3%
3.1%
Q1 24
0.3%
5.5%
Cash Conversion
BWMN
BWMN
RGEN
RGEN
Q4 25
4.76×
1.93×
Q3 25
1.54×
3.23×
Q2 25
0.71×
1.92×
Q1 25
2.57×
Q4 24
2.02×
Q3 24
8.81×
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons